Andrew Bastawrous is CEO and co-founder of Peek Vision, a social enterprise that develops smartphone technology and public health tools to help eye health organizations improve their services. Bastawrous is also an ophthalmologist and associate professor in international eye health at the London School of Hygiene & Tropical Medicine. He has worked and undertaken research in over 20 countries, including two years in Kenya where he led a major eye disease study, and the development of Peek.

Andrew Black is the team leader (development assistance) at the Secretariat of the WHO Framework Convention on Tobacco Control (WHO FCTC). Before joining the Secretariat of the WHO FCTC in 2016, Andrew was a civil servant at the United Kingdom Department of Health, where he had many roles, including tobacco program manager for almost a decade.

Andrew Bredenkamp is board chair of Translators without Borders. He has over 20 years of experience in multilingual content development and is the founder of a language artificial intelligence company based in Berlin. He has been working for the last six months on special tech projects in Congo and beyond.

Andrew Green, a 2025 Alicia Patterson Fellow, works as a contributing reporter for Devex from Berlin.

Andrew, before moving to project management, worked at world-renowned think tanks, major trade associations, in the political realm providing in-depth research and policy analysis on a range of transnational issues. Andrew exemplifies Office:FMA's research methodology and approach to problem solving, focusing on understanding the conflicting and congruent motivations for groups of actors in complex environments.

Andrew Herscowitz is the CEO of Rockefeller Catalytic Capital’s Mission 300 Accelerator. His previous roles include executive director of ODI North America, chief development officer at the U.S. International Development Finance Corporation, and coordinator for Power Africa.

Andrew Hexter is the vice president and general manager of Gilead Sciences Asia 5. He has held key roles in leading pharmaceutical companies and remains a dedicated leader of creating a healthier Asia.

Andrew Johnson is a manager in Strategic Solutions and Communications at Chemonics, an international development company working to help people live healthier, more productive, and more independent lives. Based in Washington, D.C., he has been with Chemonics for the past three years.

Andrew Kyambadde is a results-oriented development specialist with over 25 years of experience in planning, designing, implementing, managing, monitoring, and evaluating complex health programs in the public and private sectors. At RTI International, he is the health systems strengthening lead for USAID’s Act to End NTDs | East program, a global flagship initiative to support governments in ending NTDs. Previously, Kyambadde spent over two decades supporting USAID in Uganda.